CBP/p300 |
CPI-637 |
Binds to bromodomain of CBP/p300, inhibits MYC expression |
|
Taylor et al. (2016)
|
NEO2734 |
Induces depletion of Myc and inhibition of multiple myeloma growth |
|
Spriano et al. (2020)
|
NEO1132 |
|
|
WDR5 |
Compound 12 |
Strongly interrupts the interaction of WDR5-Myc complex |
|
Chacón Simon et al. (2020)
|
Compound 16 |
Reduces Myc recruitment to chromatin at WDR5-Myc co-bound genes |
|
Tian et al. (2020)
|
P-TEFb |
KL-1 |
Downregulates Myc and transcriptional regulated by Myc by destroying the P-TEFb complex |
|
Liang et al. (2018)
|
KL-2 |
|
CYC065 |
Hinders the transcriptional activation of N-Myc by inhibiting the Cdk9 of P-TEFb |
|
Poon et al. (2020)
|
Atuveciclib (BAY 1143572) |
Inhibits phosphorylation of RNAPII and reduces Myc level |
|
Lücking et al. (2017); Narita et al. (2017)
|
UNC10112785 |
Destabilizes and induces the substantial loss of Myc protein |
|
Blake et al. (2019)
|
SNS-032 |
Represses the c-Myc-dependent transcription of RhoA gene |
|
Zhang et al. (2019)
|
HDAC |
Vorinostat (SAHA) |
Induces c-Myc acetylation at lysine 323, disrupts Myc’s transcriptional repression |
|
Nebbioso et al. (2017)
|
entinostat (MS27-275) |
|
Panobinostat (LBH589) |
Reduces Myc protein level |
|
Beyer et al. (2019)
|
RGFP966 |
Remits Myc-mediated transcriptional repression of the miR-15 and let-7 families in malignant cells |
|
Konstantinopoulos et al. (2006); Adams et al. (2016)
|
depsipeptide (FK228) |
|
CD532 |
Breaks the native conformation of Aurora-A and drives the degradation of N-Myc protein |
|
Gustafson et al. (2014)
|
Aurora-A |
Alisertib |
Disrupts the N-Myc-Aurora-A complex, inhibits N-Myc signaling |
|
Beltran et al. (2019)
|
CCT137690 |
Reduces N-Myc protein in a dose-dependent manner |
|
Ommer et al. (2020)
|